Charmacy Pharmaceutical Co., Ltd. (2289.HK)

HKD 9.0

(0.0%)

EBITDA Summary of Charmacy Pharmaceutical Co., Ltd.

Charmacy Pharmaceutical Co., Ltd.'s latest annual EBITDA in 2023 was 136.92 Million CNY , up 18.99% from previous year.
Charmacy Pharmaceutical Co., Ltd.'s latest quarterly EBITDA in 2024 Q2 was 83.43 Million CNY , up 25.67% from previous quarter.
Charmacy Pharmaceutical Co., Ltd. reported an annual EBITDA of 119.18 Million CNY in 2022, up 15.14% from previous year.
Charmacy Pharmaceutical Co., Ltd. reported an annual EBITDA of 107.55 Million CNY in 2021, down -5.78% from previous year.
Charmacy Pharmaceutical Co., Ltd. reported a quarterly EBITDA of 61.7 Million CNY for 2023 Q2, up 0.86% from previous quarter.
Charmacy Pharmaceutical Co., Ltd. reported a quarterly EBITDA of N/A for 2023 FY, up 18.99% from previous quarter.

Annual EBITDA Chart of Charmacy Pharmaceutical Co., Ltd. (2023 - 2013)

Historical Annual EBITDA of Charmacy Pharmaceutical Co., Ltd. (2023 - 2013)

Year	EBITDA	EBITDA Growth
2023	136.92 Million CNY	18.99%
2022	119.18 Million CNY	15.14%
2021	107.55 Million CNY	-5.78%
2020	111.03 Million CNY	3.36%
2019	110.14 Million CNY	-9.55%
2018	113.8 Million CNY	20.12%
2017	99.39 Million CNY	3.06%
2016	94.93 Million CNY	2.07%
2015	93 Million CNY	26.98%
2014	73.24 Million CNY	33.57%
2013	54.83 Million CNY	0.0%

Year	EBITDA	EBITDA Growth
2024 Q2	83.43 Million CNY	25.67%
2023 Q2	61.7 Million CNY	0.86%
2023 FY	- CNY	18.99%
2023 Q4	66.38 Million CNY	7.6%
2022 FY	- CNY	15.14%
2022 Q4	61.17 Million CNY	2.21%
2022 Q2	59.85 Million CNY	78.51%
2021 FY	- CNY	-5.78%
2021 Q2	69.98 Million CNY	59.69%
2021 Q4	33.52 Million CNY	-52.09%
2020 Q4	43.82 Million CNY	-33.64%
2020 Q2	66.04 Million CNY	183.67%
2020 FY	- CNY	3.36%
2019 Q4	23.28 Million CNY	-71.96%
2019 Q2	83.02 Million CNY	196.73%
2019 FY	- CNY	-9.55%
2018 Q2	89.54 Million CNY	288.74%
2018 Q4	27.97 Million CNY	-68.75%
2018 FY	- CNY	20.12%
2017 Q4	23.03 Million CNY	-69.21%
2017 FY	- CNY	3.06%
2017 Q2	74.8 Million CNY	107.87%
2016 Q4	35.98 Million CNY	-38.96%
2016 Q2	58.95 Million CNY	27.7%
2016 FY	- CNY	2.07%
2015 Q2	46.84 Million CNY	66.61%
2015 FY	- CNY	26.98%
2015 Q4	46.16 Million CNY	-1.46%
2014 FY	- CNY	33.57%
2014 Q2	45.13 Million CNY	123.67%
2014 Q4	28.11 Million CNY	-37.7%
2013 FY	- CNY	0.0%
2013 Q4	20.17 Million CNY	0.0%

Peer EBITDA Comparison of Charmacy Pharmaceutical Co., Ltd.

Name	EBITDA	EBITDA Difference
Wanjia Group Holdings Limited	-29.02 Million HKD	571.741%
China Health Group Limited	-37.41 Million HKD	465.918%
Tai United Holdings Limited	-1.18 Billion HKD	111.553%